title: Management of atrial fibrillation by Canadian electrophysiologists after early termination of the PALLAS study.
authors.forename: Kiarash
authors.initials: K
authors.lastname: Mohajer
authors.forename: Ben
authors.initials: B
authors.lastname: Fregeau
authors.forename: Vinay
authors.initials: V
authors.lastname: Garg
authors.forename: Allan
authors.initials: A
authors.lastname: Skanes
authors.forename: Christopher S
authors.initials: CS
authors.lastname: Simpson
authors.forename: Damian P
authors.initials: DP
authors.lastname: Redfearn
authors.forename: Kevin A
authors.initials: KA
authors.lastname: Michael
authors.forename: Adrian
authors.initials: A
authors.lastname: Baranchuk
mesh_terms: D000889:Anti-Arrhythmia Agents / Q000627:therapeutic use*; D001281:Atrial Fibrillation / Q000188:drug therapy* / Q000503:physiopathology; D002170:Canada; D022062:Electrophysiologic Techniques, Cardiac / Q000379:methods*; D006801:Humans; D016032:Randomized Controlled Trials as Topic
chemical_list: D000889:Anti-Arrhythmia Agents